ABNB vs ACN Stock Comparison
Scores Breakdown
| Metric | ABNB | ACN |
|---|---|---|
| 📈 Growth | 14/30 | 22/30 |
| 💰 Profitability | 18/20 | 18/20 |
| 🏦 Financial Health | 15/20 | 18/20 |
| 💵 Valuation | 10/20 | 16/20 |
| ⚠️ Risk (lower is better) | 6/10 | 4/10 |
| Overall Score | 61/100 | 80/100 |
Side-by-Side Summaries
| ABNB Analysis | ACN Analysis |
|---|---|
📈 Growth & Financial Trajectory8 quarters show revenue starting at 2.748B (2024 Q2) and ending at 2.678B (2026 Q1), a small decline; a peak of 4.095B in 2025 Q3 underscores episodic demand strength. Net income rose from 461M in 2024 Q2 to a high of 1.374B in 2025 Q3, then declined to 160M in 2026 Q1, highlighting volatility with a mid-period peak. 💰 Margins & Cash FlowGross margin remains elevated, with gross_profit relative to revenue above ~75-85%; for 2026 Q1, gross_profit 2.097B vs. revenue 2.678B implies ~78% margin. Operating cash flow has been positive in most quarters, notably 1.708B in 2026 Q1 and 1.356B in 2025 Q3, while investing activities are generally negative and financing moves swing cash flow. 🛡️ Balance Sheet & LiquidityBalance sheet shows resilient assets of about $26.8B with current assets around $23.6B and equity near $7.64B in 2026 Q1; debt includes $2.48B long-term, supporting liquidity. This mix supports liquidity even in travel-cycle downturns, though elevated liabilities vs. equity suggest moderate leverage. ⚠️ Key Drivers & Risks
|
📈 Growth & Financial TrajectoryOver 8 quarters, revenues moved from $16.41B (2024 Q4) to $18.72B (2026 Q3), a cumulative rise of about 14%. Net income increased from roughly $1.68B to $2.34B, up about 39%, signaling improving operating leverage as scale widens. The trend shows quarterly fluctuations but an overall positive trajectory with gradually rising profitability. 💰 Margins & Cash Flow
🛡️ Balance Sheet & Liquidity
⚠️ Key Drivers & Risks
|